Nuvation Bio
NUVB
125 hedge funds and large institutions have $183M invested in Nuvation Bio in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 50 increasing their positions, 36 reducing their positions, and 12 closing their positions.
39% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 36
8% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 12
1% more funds holding
Funds holding: 124 → 125 (+1)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1.05% less ownership
Funds ownership: 63.58% → 62.53% (-1%)
27% less capital invested
Capital invested by funds: $250M → $183M (-$66.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$8.84M |
| 2 |
Millennium Management
New York
|
+$2.04M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
+$2.04M |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$435K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$407K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$10.5M |
| 2 |
B
Braidwell
Stamford,
Connecticut
|
-$7.42M |
| 3 |
Axa
Paris,
France
|
-$628K |
| 4 |
6CM
683 Capital Management
New York
|
-$542K |
| 5 |
BlackRock
New York
|
-$366K |
NUVB Hedge Fund Activity: Q3 2023 in Review
125 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio (NUVB) for Q3 2023, worth a combined $183M — down 27% from $250M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new NUVB positions and 12 closed out — a net gain of 1 holder — while 50 added to existing stakes and 36 trimmed.
The largest buyer was EcoR1 Capital, adding an estimated $8.84M. The largest seller was Deerfield Management, exiting entirely with an estimated $10.5M sold.
- 125 institutional investors held Nuvation Bio (NUVB) as of Q3 2023, up from 124 in Q2 2023.
- Funds reported $183M of Nuvation Bio stock for Q3 2023, down 27% quarter-over-quarter.
- 13 funds opened new Nuvation Bio positions in Q3 2023 and 12 closed out, a net change of +1 holder.
- The largest Nuvation Bio buyer in Q3 2023 was EcoR1 Capital, an estimated $8.84M added.
- The largest Nuvation Bio seller in Q3 2023 was Deerfield Management, an estimated $10.5M sold.
Based on aggregated 13F filings for Q3 2023.